Domperidone: Review of pharmacology and clinical applications in gastroenterology

American Journal of Gastroenterology

Volumn 102, Issue 9, 2007, Pages 2036-2045

  Reddymasu, Savio C ^a   Soykan, Irfan ^a   McCallum, Richard W ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CISAPRIDE; DOMPERIDONE; DOPAMINE 2 RECEPTOR; ITOPRIDE; LEVODOPA; METOCLOPRAMIDE; RANITIDINE;

AKATHISIA; ANOREXIA; ANXIETY; BLOATING; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIABETIC GASTROPATHY; DIARRHEA; DROWSINESS; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DYSPEPSIA; DYSTONIA; EXTRAPYRAMIDAL SYNDROME; FATIGUE; GASTROESOPHAGEAL REFLUX; GYNECOMASTIA; HEADACHE; HUMAN; INSOMNIA; MONOTHERAPY; NAUSEA; NAUSEA AND VOMITING; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; QUALITY OF LIFE; RAT STRAIN; RESTLESSNESS; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; STOMACH DISEASE; STOMACH PARESIS; TARDIVE DYSKINESIA; TORTICOLLIS; VOMITING; XEROSTOMIA;

ANTIEMETICS; DOMPERIDONE; DOPAMINE ANTAGONISTS; GASTROINTESTINAL DISEASES; HUMANS; NAUSEA; VOMITING;

EID: 34548139349     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01255.x     Document Type: Review

References (98)

1. Stern WR. Summary of the 34th meeting of the Food and Drug Administration Gastrointestinal Drugs Advisory Committee. March 15 and 16, 1989 (omeprazole and domperidone). Am J Gastroenterol 1989 84 : 1351 5.
2. McCallum RW. Review of the current status of prokinetic agents in gastroenterology. Am J Gastroenterol 1985 80 : 1008 16.
3. Chaudhuri TK, Fink S. Gastric emptying in human disease states. Am J Gastroenterol 1991 86 : 533 8.
4. Lazareno S, Nahorski SR. Selective labelling of dopamine (D2) receptors in rat striatum by [3H ]domperidone but not by [3H ]spiperone. Eur J Pharmacol 1982 81 : 273 85.
5. Martres MP, Baudry M, Schwartz JC. Characterization of 3H-domperidone binding on striatal dopamine receptors. Life Sci 1978 23 : 1781 4.
6. Laduron PM, Leysen JE. Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity. Biochem Pharmacol 1979 28 : 2161 5.
7. Jezova D, Johansson BB, Oprsalova Z, et al. Changes in blood-brain barrier function modify the neuroendocrine response to circulating substances. Neuroendocrinology 1989 49 : 428 33.
8. Van Nueten JM, Ennis C, Helsen L, et al. Inhibition of dopamine receptors in the stomach: An explanation of the gastrokinetic properties of domperidone. Life Sci 1978 23 : 453 7.
9. Dhasmana KM, Banerjee AK, Zhu YN, et al. Role of dopamine receptors in gastrointestinal motility. Res Commun Chem Pathol Pharmacol 1989 64 : 485 8.
10. Milanes MV, Martinez JA, Vargas ML. Influence of dopaminergic and noradrenergic systems on the release of opioid peptides in guinea-pig ileum. J Pharm Pharmacol 1989 41 : 607 11.
11. Takahashi T, Kurosawa S, Wiley JW, et al. Mechanism for the gastrokinetic action of domperidone. In vitro studies in guinea pigs. Gastroenterology 1991 101 : 703 10.
12. Champion MC, Hartnett M, Yen M. Domperidone, a new dopamine antagonist. CMAJ 1986 135 : 457 61.
13. Heykants J, Hendriks R, Meuldermans W, et al. On the pharmacokinetics of domperidone in animals and man. IV. The pharmacokinetics of intravenous domperidone and its bioavailability in man following intramuscular, oral and rectal administration. Eur J Drug Metab Pharmacokinet 1981 6 : 61 70.
14. Brogden RN, Carmine AA, Heel RC, et al. Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic. Drugs 1982 24 : 360 400.
15. Meuldermans W, Hurkmans R, Swysen E, et al. On the pharmacokinetics of domperidone in animals and man III. Comparative study on the excretion and metabolism of domperidone in rats, dogs and man. Eur J Drug Metab Pharmacokinet 1981 6 : 49 60.
16. Michiels M, Hendriks R, Heykants J. On the pharmacokinetics of domperidone in animals and man II. Tissue distribution, placental and milk transfer of domperidone in the Wistar rat. Eur J Drug Metab Pharmacokinet 1981 6 : 37 48.
17. Hofmeyr GJ, Van Iddekinge B, Blott JA. Domperidone: Secretion in breast milk and effect on puerperal prolactin levels. Br J Obstet Gynaecol 1985 92 : 141 4.
18. Weihrauch TR, Forster CF, Krieglstein J. Evaluation of the effect of domperidone on human oesophageal and gastroduodenal motility by intraluminal manometry. Postgrad Med J 1979 55 (Suppl 1 7 10.
19. Friedman G. The GI drug column. Subcommittee on FDA related matters, American College of Gastroenterology. Am J Gastroenterol 1983 78 : 47 8.
20. Broekaert A. Effect of domperidone on gastric emptying and secretion. Postgrad Med J 1979 55 (Suppl 1 11 4.
21. Reynolds JC. Prokinetic agents: A key in the future of gastroenterology. Gastroenterol Clin North Am 1989 18 : 437 57.
22. Jo YH, Sim SS, Choi H, et al. Effect of dopamine on electrical activity of isolated stomach muscle in cats. Dig Dis Sci 1989 34 : 548 52.
23. Williams PJ, MacVicar BA, Pittman QJ. Synaptic modulation by dopamine of calcium currents in rat pars intermedia. J Neurosci 1990 10 : 757 63.
24. Marzio L, Neri M, Pieramico O, et al. Dopamine interrupts gastrointestinal fed motility pattern in humans. Effect on motilin and somatostatin blood levels. Dig Dis Sci 1990 35 : 327 32.
25. Valenzuela JE. Dopamine as a possible neurotransmitter in gastric relaxation. Gastroenterology 1976 71 : 1019 22.
26. Valenzuela JE, Liu DP. The effect of variations in intragastric pressure and gastric emptying of a saline meal in humans. Scand J Gastroenterol 1982 17 : 293 6.
27. Bityutskiy LP, Soykan I, McCallum RW. Viral gastroparesis: A subgroup of idiopathic gastroparesis-clinical characteristics and long-term outcomes. Am J Gastroenterol 1997 92 : 1501 4.
28. Kendall BJ, McCallum RW. Gastroparesis and the current use of prokinetic drugs. Gastroenterologist 1993 1 : 107 14.
29. Abell TL, Bernstein VK, Cutts T, et al. Treatment of gastroparesis: A multidisciplinary clinical review. Neurogastroenterol Motil 2006 18 : 263 83.
30. Albibi R, McCallum RW. Metoclopramide: Pharmacology and clinical application. Ann Intern Med 1983 98 : 86 95.
31. Brown CK, Khanderia U. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis. Clin Pharm 1990 9 : 357 65.
32. Heer M, Muller-Duysing W, Benes I, et al. Diabetic gastroparesis: Treatment with domperidone-a double-blind, placebo-controlled trial. Digestion 1983 27 : 214 7.
33. Horowitz M, Harding PE, Chatterton BE, et al. Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy. Dig Dis Sci 1985 30 : 1 9.
34. Baeyens R, Van de Velde E, De Schepper A, et al. Effects of intravenous and oral domperidone on the motor function of the stomach and small intestine. Postgrad Med J 1979 55 (Suppl 1 19 23.
35. Davis RH, Clench MH, Mathias JR. Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms: A double-blind, placebo-controlled study. Dig Dis Sci 1988 33 : 1505 11.
36. Koch KL, Stern RM, Stewart WR, et al. Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: Effect of long-term domperidone treatment. Am J Gastroenterol 1989 84 : 1069 75.
37. Patterson D, Abell T, Rothstein R, et al. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol 1999 94 : 1230 4.
38. Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 1983 98 : 378 84.
39. Keshavarzian A, Iber FL, Vaeth J. Gastric emptying in patients with insulin-requiring diabetes mellitus. Am J Gastroenterol 1987 82 : 29 35.
40. Wegener M, Borsch G, Schaffstein J, et al. Gastrointestinal transit disorders in patients with insulin-treated diabetes mellitus. Dig Dis 1990 8 : 23 36.
41. Hasler WL, Soudah HC, Dulai G, et al. Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins. Gastroenterology 1995 108 : 727 36.
42. Silvers D, Kipnes M, Broadstone V, et al. Domperidone in the management of symptoms of diabetic gastroparesis: Efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group. Clin Ther 1998 20 : 438 53.
43. Maddern GJ, Kiroff GK, Leppard PI, et al. Domperidone, metoclopramide, and placebo. All give symptomatic improvement in gastroesophageal reflux. J Clin Gastroenterol 1986 8 : 135 40.
44. Masci E, Testoni PA, Passaretti S, et al. Comparison of ranitidine, domperidone maleate and ranitidine + domperidone maleate in the short-term treatment of reflux oesophagitis. Drugs Exp Clin Res 1985 11 : 687 92.
45. Cucchiara S, Salvia G, Borrelli O, et al. Gastric electrical dysrhythmias and delayed gastric emptying in gastroesophageal reflux disease. Am J Gastroenterol 1997 92 : 1103 8.
46. Soykan I, Lin Z, Jones S, et al. Gastric myoelectrical activity, gastric emptying and correlations with dyspepsia symptoms in patients with gastroesophageal reflux. J Investig Med 1997 45 : 483 7.
47. Cutts TF, Abell TL, Karas JG, et al. Symptom improvement from prokinetic therapy corresponds to improved quality of life in patients with severe dyspepsia. Dig Dis Sci 1996 41 : 1369 78.
48. Arts E, Anthoni H, De Roy G, et al. Domperidone in the treatment of dyspepsia: A double-blind placebo-controlled study. J Int Med Res 1979 7 : 158 61.
49. Milo R. Use of the peripheral dopamine antagonist, domperidone, in the management of gastro-intestinal symptoms in patients with irritable bowel syndrome. Curr Med Res Opin 1980 6 : 577 84.
50. Talley NJ, Locke GR 3rd., Lahr BD, et al. Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut 2006 55 : 933 9.
51. Veldhuyzen Van Zanten SJ, Jones MJ, Verlinden M, et al. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: A meta-analysis. Am J Gastroenterol 2001 96 : 689 96.
52. Van Eygen M, Dhondt F, Heck E, et al. A double-blind comparison of domperidone and metoclopramide suppositories in the treatment of nausea and vomiting in children. Postgrad Med J 1979 55 (Suppl 1 36 9.
53. Fragen RJ, Caldwell N. A new benzimidazole antiemetic, domperidone, for the treatment of postoperative nausea and vomiting. Anesthesiology 1978 49 : 289 90.
54. Zegveld C, Knape H, Smits J, et al. Domperidone in the treatment of postoperative vomiting: A double-blind multicenter study. Anesth Analg 1978 57 : 700 3.
55. Stockman A, Caron D, Gallant J, et al. Postoperative nausea and vomiting treated with domperidone (r 33812) an open and a double-blind study. Anaesthesist 1978 27 : 540 3.
56. Van Leeuwen L, Helmers JH. The efficacy of domperidone (R 33812) in the treatment of postoperative vomiting. A double-blind study with a placebo. Anaesthesist 1980 29 : 490 3.
57. Korttila K, Kauste A, Auvinen J. Comparison of domperidone, droperidol, and metoclopramide in the prevention and treatment of nausea and vomiting after balanced general anesthesia. Anesth Analg 1979 58 : 396 400.
58. Hamers J. Cytostatic therapy-induced vomiting inhibited by domperidone. A double-blind cross-over study. Biomedicine 1978 29 : 242 4.
59. Huys J. Cytostatic-associated vomiting effectively inhibited by domperidone (R 33 812). Cancer Chemother Pharmacol 1978 1 : 215 8.
60. Quinn N, Illas A, Lhermitte F, et al. Bromocriptine and domperidone in the treatment of Parkinson disease. Neurology 1981 31 : 662 7.
61. Agid Y, Pollak P, Bonnet AM, et al. Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease. Lancet 1979 1 : 570 2.
62. Soykan I, Sarosiek I, Shifflett J, et al. Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease. Mov Disord 1997 12 : 952 7.
63. Swann IL, Thompson EN, Qureshi K. Domperidone or metoclopramide in preventing chemotherapeutically induced nausea and vomiting. BMJ 1979 2 : 1188.
64. O'Meara A, Mott MG. Domperidone as an antiemetic in paediatric oncology. Cancer Chemother Pharmacol 1981 6 : 147 9.
65. De Loore I, Van Ravensteyn H, Ameryckx L. Domperidone drops in the symptomatic treatment of chronic paediatric vomiting and regurgitation. A comparison with metoclopramide. Postgrad Med J 1979 55 (Suppl 1 40 2.
66. Clara R, Van Hollebeke J, Heck E. A multicentre pilot study of parenteral and rectal administration of domperidone in the treatment of severe vomiting in children. Postgrad Med J 1979 55 (Suppl 1 43 4.
67. Grill BB, Hillemeier AC, Semeraro LA, et al. Effects of domperidone therapy on symptoms and upper gastrointestinal motility in infants with gastroesophageal reflux. J Pediatr 1985 106 : 311 6.
68. Extrapyramidal reactions due to domperidone. Lancet 1980 2 : 802.
69. Weaving A, Bezwoda WR, Derman DP. Seizures after antiemetic treatment with high dose domperidone: Report of four cases. BMJ (Clin Res Ed) 1984 288 : 1728.
70. Bonuccelli U, Nocchiero A, Napolitano A, et al. Domperidone-induced acute dystonia and polycystic ovary syndrome. Mov Disord 1991 6 : 79 81.
71. Drolet B, Rousseau G, Daleau P, et al. Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation 2000 102 : 1883 5.
72. Wolbrette DL. Risk of proarrhythmia with class III antiarrhythmic agents: Sex-based differences and other issues. Am J Cardiol 2003 91 : 39D 44D.
73. Spirt MJ, Chan W, Thieberg M, et al. Neuroleptic malignant syndrome induced by domperidone. Dig Dis Sci 1992 37 : 946 8.
74. McCallum RW. Clinical pharmacology forum: Motility agents and the gastrointestinal tract. Am J Med Sci 1996 312 : 19 26.
75. Sowers JR, Sharp B, McCallum RW. Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man. J Clin Endocrinol Metab 1982 54 : 869 71.
76. Langer SZ, Vidal M, Duval N. Presynaptic dopamine receptors in the cardiovascular system. Clin Exp Hypertens A 1987 9 : 837 51.
77. Giaccone G, Bertetto O, Calciati A. Two sudden deaths during prophylactic antiemetic treatment with high doses of domperidone and methylprednisolone. Lancet 1984 2 : 1336 7.
78. Foldes J, Banos C, Lakatos P, et al. Effect of domperidone on serum TSH and growth hormone in thyroid patients. Acta Medica Hungarica 1985 42 : 133 43.
79. Foldes J, Banos C, Lakatos P, et al. [Effect of a dopamine receptor blockader (domperidone) on serum TSH and growth hormone levels in patients with thyroid diseases ]. Orvosi Hetilap 1984 125 : 3095 101.
80. Osborne RJ, Slevin ML, Hunter RW, et al. Cardiotoxicity of intravenous domperidone. Lancet 1985 2 : 385.
81. Roussak JB, Carey P, Parry H. Cardiac arrest after treatment with intravenous domperidone. BMJ (Clin Res Ed) 1984 289 : 1579.
82. Tatsuta M, Iishi H, Nakaizumi A, et al. Effect of treatment with cisapride alone or in combination with domperidone on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther 1992 6 : 221 8.
83. Sawant P, Das HS, Desai N, et al. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia. J Assoc Physicians India 2004 52 : 626 8.
84. Bekhti A, Rutgeerts L. Domperidone in the treatment of functional dyspepsia in patients with delayed gastric emptying. Postgrad Med J 1979 55 (Suppl 1 30 2.
85. Haarmann K, Lebkuchner F, Widmann A, et al. A double-blind study of domperidone in the symptomatic treatment of chronic post-prandial upper gastrointestinal distress. Postgrad Med J 1979 55 (Suppl 1 24 7.
86. Sarin SK, Sharma P, Chawla YK, et al. Clinical trial on the effect of domperidone on non-ulcer dyspepsia. Indian J Med Res 1986 83 : 623 8.
87. Bradette M, Pare P, Douville P, et al. Visceral perception in health and functional dyspepsia. Crossover study of gastric distension with placebo and domperidone. Dig Dis Sci 1991 36 : 52 8.
88. Boulanger M, Dubois A, Lecron L. Domperidone in the prevention of post-operative nausea and vomiting. Postgrad Med J 1979 55 (Suppl 1 45 7.
89. Cooke RD, Comyn DJ, Ball RW. Prevention of postoperative nausea and vomiting by domperidone: A double-blind randomized study using domperidone, metoclopramide and a placebo. S Afr Med J 1979 56 : 827 9.
90. Boghaert A, Carron D, Gallant J, et al. Postoperative vomiting treated with domperidone. A double-blind comparison with metoclopramide and a placebo. Acta Anaesthesiol Belg 1980 31 : 129 37.
91. Spelina KR, Gerber HR, Pagels IL. Nausea and vomiting during spinal anaesthesia. Effect of metoclopramide and domperidone: A double-blind trial. Anaesthesia 1984 39 : 132 7.
92. Waldmann CS, Verghese C, Short SM, et al. The evaluation of domperidone and metoclopramide as antiemetics in day care abortion patients. Br J Clin Pharmacol 1985 19 : 307 10.
93. Madej TH, Simpson KH. Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following gynaecological surgery in day cases. Br J Anaesth 1986 58 : 879 83.
94. Madej TH, Simpson KH. Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following major gynaecological surgery. Br J Anaesth 1986 58 : 884 7.
95. Roila F, Tonato M, Basurto C, et al. Double-blind controlled trial of the antiemetic efficacy and toxicity of methylprednisolone (MP), metoclopramide (MTC) and domperidone (DMP) in breast cancer patients treated with i.v. CMF. Eur J Cancer Clin Oncol 1987 23 : 615 7.
96. Soykan I, Sarosiek I, McCallum RW. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol 1997 92 : 976 80.
97. Chey WY, You CH, Ange DA. Open and double-blind clinical trials of domperidone in patients with unexplained nausea, vomiting, abdominal bloating, and early satiety. Gastroenterology 1982 82 : 1033.
98. Van Ganse W, Van Damme L, Van de Mierop L, et al. Chronic dyspepsia: Double-blind treatment with domperidone (R 33 812) or a placebo. A multicentre therapeutic evaluation. Curr Ther Res 1978 23 : 695 700.